Cerenome (CNSY) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.70, -9.57% vs the prior close of $1.88.
- Volume 84.94K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CNSY slides 9.6% to $1.70. Closed at $1.70, -9.57% vs the prior close of $1.88. Day range $1.70–$1.96, opened at $1.91.
CNSY daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CNSY slides 9.6% to $1.70
- Closed at $1.70, -9.57% vs the prior close of $1.88. Day range $1.70–$1.96, opened at $1.91.
- Volume was 84.94K shares, 0.7x its 50-day average of 119.44K.
- Price is -31.5% vs its 50-day average ($2.48) and -67.3% vs its 200-day average ($5.19).
- 52-week range $1.49–$19.00; today's close sits at 1% of that range, 91.1% below the 52-week high.
Oct 15, 2026 — CNSY jumps 11.2% to $1.88
- Closed at $1.88, +11.24% vs the prior close of $1.69. Day range $1.66–$1.92, opened at $1.66.
- Volume was 111.70K shares, 0.9x its 50-day average of 118.48K.
- Price is -25.5% vs its 50-day average ($2.52) and -64.2% vs its 200-day average ($5.25).
- 52-week range $1.49–$19.00; today's close sits at 2% of that range, 90.1% below the 52-week high.
Oct 14, 2026 — CNSY dips 2.9% to $1.69, 3 down days in a row
- Closed at $1.69, -2.87% vs the prior close of $1.74. Day range $1.55–$1.76, opened at $1.76.
- Volume was 82.10K shares, 0.7x its 50-day average of 119.60K.
- Price is -34.1% vs its 50-day average ($2.56) and -68.2% vs its 200-day average ($5.31).
- 52-week range $1.49–$19.00; today's close sits at 1% of that range, 91.1% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — CNSY slides 3.9% to $1.74
- Closed at $1.74, -3.87% vs the prior close of $1.81. Day range $1.64–$1.81, opened at $1.80.
- Volume was 116.50K shares, 1.0x its 50-day average of 120.20K.
- Price is -33.3% vs its 50-day average ($2.61) and -67.6% vs its 200-day average ($5.38).
- 52-week range $1.49–$19.00; today's close sits at 1% of that range, 90.8% below the 52-week high.
Oct 12, 2026 — CNSY slides 6.2% to $1.81
- Closed at $1.81, -6.22% vs the prior close of $1.93. Day range $1.80–$1.92, opened at $1.92.
- Volume was 52.40K shares, 0.4x its 50-day average of 121.07K — lighter than usual.
- Price is -31.6% vs its 50-day average ($2.65) and -66.7% vs its 200-day average ($5.44).
- 52-week range $1.49–$19.00; today's close sits at 2% of that range, 90.5% below the 52-week high.
Oct 9, 2026 — CNSY jumps 7.8% to $1.93, 4 up days in a row
- Closed at $1.93, +7.82% vs the prior close of $1.79. Day range $1.80–$1.96, opened at $1.80.
- Volume was 152.10K shares, 1.3x its 50-day average of 119.07K.
- Price is -28.2% vs its 50-day average ($2.69) and -64.9% vs its 200-day average ($5.50).
- 52-week range $1.49–$20.00; today's close sits at 2% of that range, 90.4% below the 52-week high.
- That makes 4 straight gains.
Oct 8, 2026 — CNSY jumps 9.1% to $1.79, 3 up days in a row
- Closed at $1.79, +9.15% vs the prior close of $1.64. Day range $1.60–$1.80, opened at $1.68.
- Volume was 122.70K shares, 1.0x its 50-day average of 118.49K.
- Price is -34.2% vs its 50-day average ($2.72) and -67.8% vs its 200-day average ($5.56).
- 52-week range $1.49–$20.25; today's close sits at 2% of that range, 91.2% below the 52-week high.
- That makes 3 straight gains.
Oct 7, 2026 — CNSY jumps 3.1% to $1.64
- Closed at $1.64, +3.14% vs the prior close of $1.59. Day range $1.56–$1.71, opened at $1.62.
- Volume was 110.90K shares, 0.9x its 50-day average of 117.36K.
- Price is -40.5% vs its 50-day average ($2.76) and -70.8% vs its 200-day average ($5.63).
- 52-week range $1.49–$21.50; today's close sits at 1% of that range, 92.4% below the 52-week high.
Oct 6, 2026 — CNSY rises 1.9% to $1.59
- Closed at $1.59, +1.92% vs the prior close of $1.56. Day range $1.54–$1.66, opened at $1.56.
- Volume was 69.60K shares, 0.6x its 50-day average of 116.95K — lighter than usual.
- Price is -43.2% vs its 50-day average ($2.80) and -72.0% vs its 200-day average ($5.69).
- 52-week range $1.49–$23.50; today's close sits at 0% of that range, 93.2% below the 52-week high.
Oct 5, 2026 — CNSY dips 2.5% to $1.56, a 52-week low on 2.0x normal volume
- Closed at $1.56, -2.50% vs the prior close of $1.60. Day range $1.49–$1.59, opened at $1.52.
- Volume was 222.90K shares, 2.0x its 50-day average of 113.84K — unusually heavy trading.
- Price is -45.1% vs its 50-day average ($2.84) and -72.9% vs its 200-day average ($5.75).
- 52-week range $1.49–$23.50; today's close sits at 0% of that range, 93.4% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — CNSY slides 10.1% to $1.60, a 52-week low on 2.0x normal volume
- Closed at $1.60, -10.11% vs the prior close of $1.78. Day range $1.54–$1.86, opened at $1.81.
- Volume was 226.50K shares, 2.0x its 50-day average of 110.59K — unusually heavy trading.
- Price is -44.6% vs its 50-day average ($2.89) and -72.5% vs its 200-day average ($5.82).
- 52-week range $1.54–$23.50; today's close sits at 0% of that range, 93.2% below the 52-week high.
- SEC filings that day: 8-K.
CNSY latest news & SEC filings
Every SEC filing by or about CNSY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Van Es-Johansson An converted options/RSUs into 921 shares on Oct 1, 2026; now holds 1,843
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hawkins Richard J converted options/RSUs into 921 shares on Oct 1, 2026; now holds 2,450
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Clowes Howard converted options/RSUs into 921 shares on Oct 1, 2026; now holds 2,902
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sims Andrew John Hugh Macintyre converted options/RSUs into 1,533 shares on Oct 1, 2026; now holds 11,474
- Sims Andrew John Hugh Macintyre converted options/RSUs into 1,165 shares on Oct 1, 2026; now holds 12,639
- Sims Andrew John Hugh Macintyre converted options/RSUs into 287 shares on Oct 1, 2026; now holds 12,926
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Andrews Ronald Asbury converted options/RSUs into 921 shares on Oct 1, 2026; now holds 1,843
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hedrick Marc H converted options/RSUs into 6,387 shares on Oct 1, 2026; now holds 50,870
- Hedrick Marc H converted options/RSUs into 8,066 shares on Oct 1, 2026; now holds 58,936
- Hedrick Marc H converted options/RSUs into 1,986 shares on Oct 1, 2026; now holds 60,922
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $411.00K (prior year $1.39M) (-70.4% vs Jun 30, 2025)
- Net income: -$9.01M (prior year $5.15M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.31 (prior year -$0.16) (loss widened vs Jun 30, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Things to know before you trade CNSY
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 15, 2026, Mar 12, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.55% (largest 11.2%). That is a volatile stock.
- Liquidity: about 186.61K shares (≈$317.24K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.70 vs a range of $1.49–$19.00 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:25 on Apr 2, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Andrew John Hugh Macintyre Sims bought 20,000 shares on Nov 4, 2025.
- Latest filings: 8-K Oct 2, 2026; 8-K Sep 10, 2026; 10-Q Aug 14, 2026.
- Share count: 7.59M shares outstanding (Aug 5, 2026), -92.4% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
CNSY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.91 | 1.96 | 1.70 | 1.70 | 84.94K |
| Oct 15, 2026 | 1.66 | 1.92 | 1.66 | 1.88 | 111.70K |
| Oct 14, 2026 | 1.76 | 1.76 | 1.55 | 1.69 | 82.10K |
| Oct 13, 2026 | 1.80 | 1.81 | 1.64 | 1.74 | 116.50K |
| Oct 12, 2026 | 1.92 | 1.92 | 1.80 | 1.81 | 52.40K |
| Oct 9, 2026 | 1.80 | 1.96 | 1.80 | 1.93 | 152.10K |
| Oct 8, 2026 | 1.68 | 1.80 | 1.60 | 1.79 | 122.70K |
| Oct 7, 2026 | 1.62 | 1.71 | 1.56 | 1.64 | 110.90K |
| Oct 6, 2026 | 1.56 | 1.66 | 1.54 | 1.59 | 69.60K |
| Oct 5, 2026 | 1.52 | 1.59 | 1.49 | 1.56 | 222.90K |
| Oct 2, 2026 | 1.81 | 1.86 | 1.54 | 1.60 | 226.50K |
| Oct 1, 2026 | 1.94 | 2.28 | 1.64 | 1.78 | 1.17M |
| Sep 30, 2026 | 2.02 | 2.02 | 1.84 | 1.87 | 226.30K |
| Sep 29, 2026 | 2.03 | 2.12 | 1.86 | 1.86 | 235.70K |
| Sep 28, 2026 | 1.99 | 2.06 | 1.90 | 2.02 | 98.00K |
| Sep 25, 2026 | 1.92 | 2.08 | 1.92 | 1.99 | 203.20K |
| Sep 24, 2026 | 1.96 | 1.96 | 1.86 | 1.87 | 86.00K |
| Sep 23, 2026 | 2.01 | 2.06 | 1.93 | 1.95 | 65.30K |
| Sep 22, 2026 | 1.93 | 2.10 | 1.91 | 2.03 | 185.10K |
| Sep 21, 2026 | 2.03 | 2.06 | 1.90 | 1.90 | 112.40K |
About Cerenome
Cerenome (CNSY) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in HOUSTON, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1095981.
CNSY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ronald Asbury Andrews | Director | Jul 1, 2026 |
| Howard Clowes | Director | Jul 1, 2026 |
| Kyle Guse | Director | Jul 1, 2026 |
| Marc H Hedrick | Chief Executive Officer | Jul 1, 2026 |
| Richard J Hawkins | Director | Jul 1, 2026 |
| Es-Johansson An Van | Director | Jul 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Eric Joseph Daniels | Chief Development Officer | Apr 22, 2026 |
| Marc H Hedrick | Chief Executive Officer | Jul 1, 2026 |
| Andrew John Hugh Macintyre Sims | Chief Financial Officer | Jul 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Nov 4, 2025 | Andrew John Hugh Macintyre Sims | Buy | 20,000 | $0.51 |
| Nov 4, 2025 | Andrew John Hugh Macintyre Sims | Buy | 20,000 | $0.51 |
| Nov 4, 2025 | Andrew John Hugh Macintyre Sims | Buy | 20,000 | $0.51 |
| Nov 4, 2025 | Andrew John Hugh Macintyre Sims | Buy | 20,000 | $0.51 |
CNSY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-22.39M | -0.29 | $-20.77M |
| Dec 31, 2024 | — | $-12.98M | -2.34 | $-10.55M |
| Dec 31, 2023 | — | $-13.32M | -4.24 | $-12.85M |
| Dec 31, 2022 | — | $-20.27M | -11.58 | $-12.97M |
| Dec 31, 2021 | — | $-13.40M | -1.11 | $-10.28M |
Latest balance sheet: total assets $14.03M, total liabilities $8.57M, cash $2.37M (as of Jun 30, 2026).
CNSY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $3.68 |
| May 15, 2026 | 8-K Item 2.02 (results) | $5.25 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $7.25 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $13.25 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $13.50 |
| May 30, 2025 | 8-K Item 2.02 (results) | $7.25 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $38.00 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $31.50 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 5, 2024 | 8-K Item 2.02 (results) | — |
| Oct 31, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CNSY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.